Literature DB >> 11064541

Posterior thoracotomy for reoperative coronary artery bypass grafting without cardiopulmonary bypass: perioperative results.

G D'Ancona1, H Karamanoukian, T Lajos, M Ricci, J Bergsland, T Salerno.   

Abstract

BACKGROUND: This retrospective study evaluates morbidity and mortality of reoperative coronary artery bypass grafting (CABG) without cardiopulmonary bypass (CPB) using a posterior thoracotomy to revascularize the lateral aspect of the heart.
METHODS: From January 1995 to July 1999, reoperative CABG without CPB was performed on 67 selected patients using a left posterior thoracotomy approach. Preoperative risk factors, postoperative mortality, and major complications were derived from the New York State database.
RESULTS: All patients were operated on without CPB. A total of 1.3 grafts per patient were performed. Freedom from major complications was 95.5%. There were no postoperative cerebro-vascular accidents (CVA) or new neurological deficits. Two patients (3%) had a perioperative acute myocardial infarction. The actual mortality rate was 4.5% (3/67), the expected mortality was 5.1% and the calculated risk adjusted mortality was 2.1%.
CONCLUSIONS: Reoperative CABG without CPB to revascularize selected coronary artery targets can be safely performed using a posterior thoracotomy approach.

Entities:  

Mesh:

Year:  2000        PMID: 11064541

Source DB:  PubMed          Journal:  Heart Surg Forum        ISSN: 1098-3511            Impact factor:   0.676


  2 in total

1.  Off-pump coronary artery bypass grafting and transmyocardial laser revascularization via a left thoracotomy.

Authors:  Igor Gregoric; Gregory Messner; Wilson J Couto; Michele Sartori; Roberto Cervera; Kamuran Kadipasaoglu; O H Frazier
Journal:  Tex Heart Inst J       Date:  2003

2.  Redo off-pump coronary artery bypass grafting via a left thoracotomy.

Authors:  I Duvan; S Ates; B E Onuk; U P Sungar; M Kurtoglu; Y H Karagoz
Journal:  Cardiovasc J Afr       Date:  2014-12-02       Impact factor: 1.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.